Philip Morris International announced a quarterly dividend increase of 8.8%, raising the payout from $1.47 to $1.60 per share. This adjustment brings the annual dividend to $6.40 per share. Eligible shareholders will receive the payment on October 26 for those on record as of October 2. The company has extended its dividend-raising streak to 19 consecutive years since its 2008 public debut, with cumulative payout increases of 248% representing a 7.2% compound annual growth rate.
The stock’s recent performance reflected broader market strength for Philip Morris International. PM rose 17% year-to-date, more than double the 8% gain recorded by the Consumer Staples Select Sector SPDR Fund. Over the past 52 weeks, the stock gained 16% and reached a 52-week high of $207.76 in late July. The valuation expanded to 22.2 times forward earnings, exceeding the consumer staples sector average of 14.6 times, reflecting investor expectations for growth and dividend reliability.
Operational results supported the dividend increase. Second-quarter revenue climbed 10.4% to $11.2 billion, or 7.6% on an organic basis, with adjusted diluted earnings per share reaching $2.20, up 15.2% year-over-year. Smoke-free product shipments surged 7.5%, accounting for approximately 42% of total sales and growing 11.7% in revenue, while traditional cigarette revenue rose 9.5%. For 2026, the company guided for organic revenue growth between 5% and 7%, organic operating income growth of 7% to 9%, and approximately $13.5 billion in operating cash flow.
Regulatory approvals bolstered the smoke-free segment. The Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products in August and earlier granted modified-risk orders to 20 flagship ZYN products, marking the first such designations for nicotine pouches and permitting marketing as lower-risk alternatives to cigarettes. Infrastructure expansion supported growth, with a new 780,000-square-foot Aurora, Colorado facility beginning commercial production of ZYN pouches in July 2026, with plans for $1.2 billion in campus investment through 2028.
Analyst sentiment remained constructive. Needham raised its price target to $215 from $200, while BTIG initiated coverage on July 21 with a $216 target. All 14 analysts covering the stock held a consensus “Moderate Buy” rating with an average price target of $207.07, implying approximately 9% upside from recent trading levels. Third-quarter earnings were expected on October 20, with consensus estimates calling for $2.34 per share, a 4.46% increase year-over-year.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI